These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11467023)

  • 1. An outbreak of acute hepatitis B infection among injecting drug users in Inverclyde, Scotland.
    Stevenson J; Tannahill M; Biggs V
    Commun Dis Public Health; 2001 Mar; 4(1):60-3. PubMed ID: 11467023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for hepatitis B in an outbreak of hepatitis B and D among injection drug users.
    Bialek SR; Bower WA; Mottram K; Purchase D; Nakano T; Nainan O; Williams IT; Bell BP
    J Urban Health; 2005 Sep; 82(3):468-78. PubMed ID: 16049202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing and prioritizing the preferences of injecting drug users in needle and syringe exchange service development.
    Matheson C; Anthony GB; Bond C; Rossi MK
    J Public Health (Oxf); 2008 Jun; 30(2):133-8. PubMed ID: 18436548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in Scotland.
    Allen EJ; Palmateer NE; Hutchinson SJ; Cameron S; Goldberg DJ; Taylor A
    Int J Drug Policy; 2012 Sep; 23(5):346-52. PubMed ID: 22940142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of drug use and associated harms among rural injecting drug users: comparisons with metropolitan injecting drug users.
    Day C; Conroy E; Lowe J; Page J; Dolan K
    Aust J Rural Health; 2006 Jun; 14(3):120-5. PubMed ID: 16706881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal uptake of sterile drug preparation equipment in a predominantly cocaine injecting population: implications for HIV and hepatitis C prevention.
    Morissette C; Cox J; De P; Tremblay C; Roy E; Allard R; Stephenson R; Graves L
    Int J Drug Policy; 2007 May; 18(3):204-12. PubMed ID: 17689367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia.
    Maher L; Chant K; Jalaludin B; Sargent P
    J Gastroenterol Hepatol; 2004 Oct; 19(10):1114-20. PubMed ID: 15377287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV infection among injecting drug users in north-east Malaysia, 1992.
    Singh S; Crofts N
    AIDS Care; 1993; 5(3):273-81. PubMed ID: 8218462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to hepatitis B virus vaccination at syringe exchange sites.
    Altice FL; Bruce RD; Walton MR; Buitrago MI
    J Urban Health; 2005 Mar; 82(1):151-61. PubMed ID: 15746385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poor hepatitis B vaccine coverage in injecting drug users: England, 1995 and 1996.
    Lamagni TL; Davison KL; Hope VD; Luutu JW; Newham JA; Parry JV; Gill ON
    Commun Dis Public Health; 1999 Sep; 2(3):174-7. PubMed ID: 10491870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B vaccination for injection drug users--Pierce County, Washington, 2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 May; 50(19):388-90, 399. PubMed ID: 11465908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus antibody prevalence among injecting drug users in Glasgow has fallen but remains high.
    Goldberg D; Cameron S; McMenamin J
    Commun Dis Public Health; 1998 Jun; 1(2):95-7. PubMed ID: 9644121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential of specialist drug services to deliver hepatitis B vaccination.
    Morrison DS; Gilchrist G; Ahmed S
    Commun Dis Public Health; 2002 Dec; 5(4):321-3. PubMed ID: 12564250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of injecting drug use and associated risk behavior among regular ecstasy users in Australia.
    White B; Day C; Degenhardt L; Kinner S; Fry C; Bruno R; Johnston J
    Drug Alcohol Depend; 2006 Jul; 83(3):210-7. PubMed ID: 16343810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High HIV and hepatitis C prevalence amongst injecting drug users in Mauritius: findings from a population size estimation and respondent driven sampling survey.
    Johnston L; Saumtally A; Corceal S; Mahadoo I; Oodally F
    Int J Drug Policy; 2011 Jul; 22(4):252-8. PubMed ID: 21700442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The natural history of injecting drug use: a 25-year longitudinal study of a cohort of injecting drug users in inner city Dublin.
    O'Kelly FD; O'Kelly CM
    Ir J Med Sci; 2012 Dec; 181(4):541-8. PubMed ID: 22430070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The efficacy of needle exchange programs in the prevention of HIV and hepatitis infection among injecting drug users].
    Takács IG; Demetrovics Z
    Psychiatr Hung; 2009; 24(4):264-81. PubMed ID: 19949245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of reduction in heroin supply on injecting drug use: analysis of data from needle and syringe programmes.
    Day C; Degenhardt L; Gilmour S; Hall W
    BMJ; 2004 Aug; 329(7463):428-9. PubMed ID: 15292056
    [No Abstract]   [Full Text] [Related]  

  • 20. Knowledge of hepatitis among active drug injectors at a syringe exchange program.
    Carey J; Perlman DC; Friedmann P; Kaplan WM; Nugent A; Deutscher M; Masson CL; Des Jarlais DC
    J Subst Abuse Treat; 2005 Jul; 29(1):47-53. PubMed ID: 15979531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.